Diagnosis Code C40.90
Information for Medical Professionals
The diagnosis code C40.90 is grouped in the following Diagnostic Related Group(s) (MS-DRG V34.0)
- 542 - PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH MCC
- 543 - PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITH CC
- 544 - PATHOLOGICAL FRACTURES AND MUSCULOSKELETAL AND CONNECTIVE TISSUE MALIGNANCY WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 170.9 - Malig neopl bone NOS (approximate) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
- Adamantinoma of long bone
Information for Patients
Cancer that starts in a bone is uncommon. Cancer that has spread to the bone from another part of the body is more common.
There are three types of bone cancer:
- Osteosarcoma - occurs most often between ages 10 and 19. It is more common in the knee and upper arm.
- Chondrosarcoma - starts in cartilage, usually after age 40
- Ewing's sarcoma - occurs most often in children and teens under 19. It is more common in boys than girls.
The most common symptom of bone cancer is pain. Other symptoms vary, depending on the location and size of the cancer. Surgery is often the main treatment for bone cancer. Other treatments may include amputation, chemotherapy, and radiation therapy. Because bone cancer can come back after treatment, regular follow-up visits are important.
NIH: National Cancer Institute
- After chemotherapy - discharge
- Bone lesion biopsy
- Bone tumor
- Ewing sarcoma
- Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
- What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)